文献速递腹部技术与安全CT

基于能谱CT定量参数联合细胞外容积分数预测胃癌淋巴结转移

Spectral computed tomography-based quantitative parameters combined with extracellular volume fraction to predict lymph node metastases in gastric cancer.
PubMed 文献 · Eur Radiol · 2025-06-03

本研究纳入70例胃癌患者的230枚淋巴结(97枚非转移、133枚转移),按6:4随机分为训练集和测试集,评估淋巴结定性特征、能谱CT定量参数及细胞外容积分数(ECV%),构建3个模型预测淋巴结转移。ECV%在阳性与阴性淋巴结间差异显著(p<0.001),诊断效能AUC在训练集和测试集分别为0.823和0.803(均p<0.001),高于其他参数。联合能谱CT定量参数与ECV%的模型3诊断效能显著高于模型1和模型2(AUC分别为0.858和0.881,均p<0.001)。

要点

  • ECV%在转移与非转移淋巴结间差异显著(p<0.001),诊断AUC训练集0.823、测试集0.803(均p<0.001)。
  • 联合能谱CT定量参数与ECV%的模型3诊断效能显著高于传统特征模型1和能谱参数模型2(均p<0.001)。
  • 模型3在训练集和测试集的AUC分别为0.858和0.881,可较准确预测区域淋巴结转移。

核心结论

  • ECV%有助于诊断胃癌淋巴结转移,能谱CT定量特征联合ECV%可进一步提高诊断效能,实现术前准确预测淋巴结转移及胃癌预后,使患者接受个体化治疗。

研究设计与样本

  • 从70例胃癌患者收集230枚淋巴结(97枚非转移、133枚转移),按6:4随机分为训练集和测试集;评估淋巴结定性特征(边缘、形状、强化程度)、能谱CT定量参数及ECV%;采用前向变量选择法的多变量逻辑回归构建3个模型:模型1(传统特征:淋巴结边缘、短轴直径)、模型2(能谱CT参数:动脉期和延迟期碘浓度)、模型3(能谱CT参数联合ECV%);用AUC评估诊断效能并行DeLong检验比较。

诊断标准与关键数值

  • ECV%诊断淋巴结转移的AUC在训练集为0.823、测试集为0.803(均p<0.001),高于其他参数;模型3的AUC在训练集为0.858、测试集为0.881,均显著高于模型1和模型2(均p<0.001)。

临床应用与阅片要点

  • 作者认为ECV%可帮助诊断胃癌淋巴结转移,能谱CT定量特征联合ECV%可进一步改善诊断,有助于术前准确预测淋巴结转移及胃癌预后,使患者接受个体化治疗。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: Preoperative prediction of lymph node metastasis (LNM) is important for gastric cancer (GC) diagnosis, treatment and prognosis. This study aimed to predict LNM risk in GC using quantitative parameters and extracellular volume fraction (ECV%) derived from spectral computed tomography (CT).

MATERIALS AND METHODS: Data from 230 lymph nodes (LNs) (97 nonmetastatic, 133 metastatic) were collected from 70 GC patients and were randomly divided into a training cohort and a test cohort (6:4 ratio). LN qualitative features (including edge, shape and degree of enhancement), spectral CT-derived quantitative parameters and ECV% were assessed. Multivariate logistic regression analysis with the forward variable selection method was used to build 3 models: Model 1 (traditional features: LN edge, short axis diameter), Model 2 (spectral CT parameters: iodine concentration in arterial and delayed phases), and Model 3 (spectral CT parameters and ECV%). Diagnostic performance was evaluated using AUC and compared with the Delong test.

RESULTS: In both cohorts, a significant difference in ECV% was observed between positive and negative LNs (p < 0.001), and the diagnostic efficacy of ECV% (AUC = 0.823 and 0.803, respectively, both p < 0.001) was higher than that of other parameters. Model 3 demonstrated significantly higher diagnostic efficacy than Models 1 and 2 in both cohorts (AUC = 0.858 and 0.881, respectively; both p < 0.001).

CONCLUSION: ECV% can help diagnose LNM in GC, and combining the spectral CT quantitative features with ECV% can further improve diagnosis. This finding enables accurate preoperative prediction of LNM and the GC prognosis so that patients receive personalized treatment.

KEY POINTS: Question Predicting lymph node metastasis (LNM) based on the LN remains a challenge; can spectral CT combined with the Extracellular volume fraction (ECV%) model predict regional LNM? Findings Based on the LN level, the spectral CT combined ECV% model could more accurately predict regional LNM in the training and test cohort. Clinical relevance Accurate and non-invasive preoperative prediction of LNM in each region is important for the individualized treatment and prognosis of gastric cancer. Assisting physicians in selecting the most appropriate treatment approaches to optimize patient outcomes.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Zhang X, Peng L, Ma F, et al. Spectral computed tomography-based quantitative parameters combined with extracellular volume fraction to predict lymph node metastases in gastric cancer. Eur Radiol. 2025. PMID: 40461708. doi:10.1007/s00330-025-11705-y

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。